New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
The US generic market is crucial for Indian pharma, contributing about 35% to its total revenue, around US$ 10.7 billion
Merck and mantro GmbH have established EdiMembre, Massachusetts, U.S.A., a Deep Tech spin-out in the alternative protein industry
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
Godavari Biorefineries receives patent from CNIPA
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
Bayer expects 2025 to be the most difficult year of its turnaround
Subscribe To Our Newsletter & Stay Updated
